The 2018 OMERACT synovial Tissue Biopsy special interest group report on standardization of synovial biopsy analysis

M. D. Wechalekar, Aurélie Najm, D. J. Veale, V. Strand

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Objective. The Outcome Measures in Rheumatology (OMERACT) synovial tissue biopsy (STB) working group initiated an international effort to standardize STB analyses, define consensual items to inform treatment choices, and predict responses in rheumatoid arthritis (RA).

Methods. (1) A Delphi survey to determine items for STB analyses. (2) A multicenter retrospective study of STB data in patients with RA posttreatment with biological disease-modifying antirheumatic drugs.

Results. The Delphi survey identified 18 STB analyses items. Consensus on histological markers was achieved in the OMERACT 2018 SIG. Conclusion. Six markers were identified for examination in a multicenter study designed to define an OMERACT-endorsed set of STB markers to predict responses to treatment.

Original languageEnglish
Pages (from-to)1365-1368
Number of pages4
JournalJournal of Rheumatology
Volume46
Issue number10
DOIs
Publication statusPublished - 1 Oct 2019

Keywords

  • Omeract
  • Synovium

Fingerprint Dive into the research topics of 'The 2018 OMERACT synovial Tissue Biopsy special interest group report on standardization of synovial biopsy analysis'. Together they form a unique fingerprint.

Cite this